• Metadoro
  • Products
  • News and analysis

News and analysis

Check market insights shared by our community members
14.01.2025
Tezos Is Seen Hodling above $1.200

Tezos (XTZ) has declined slightly by 0.2% this week, trading at $1.249, following Bitcoin’s (BTC) drop to $89,158, which triggered widespread altcoin sell-offs due to concerns of a potential further decline in BTC to $80,000. However, Bitcoin managed to hold above the critical support level at $89,000-$91,000, offering some relief to the broader crypto market.

Speculation about a shift in U.S. trade policy has provided additional support to crypto assets. Reports suggest the new U.S. administration may pursue a gradual increase in tariffs rather than an abrupt hike, which could help alleviate inflationary pressures and lead to a less aggressive monetary stance from the Federal Reserve.

This development is a positive signal for the cryptocurrency market and may help Tezos maintain its position above the key support level of $1.200.

06.02.2025
Perfect As the Enemy of Good

Here is the problem, which is nearly at a primary school level. A simple logical puzzle. A shopping street has two grocery stores. One of the stores is much more popular than the other. But both shops are full of customers every day. So both shops are raking in money. Sales output of a more popular store roughly doubled over the past year, from $14.5 billion to $30.8 billion - oh, yes, it's a very big shop - which led to tripling of its market value. Meanwhile, sales in the second store have already grown by 69%, albeit by its lower standards, namely from $2.3 billion to $3.9 billion. Please draw a conclusion, by what percentage the market value of the second store could increase, assuming that professional appraisers are rather objective. It seems ridiculous, but the correct answer is that the second store's market value lost 35% within the same year, and it even dropped by 50% from its peak price of the last spring. Holy Cow! That was a story of some failed expectations of mine. Since the big store is, of course, Nvidia, and the small one (and also, in fact, quite a prosperous marketplace) is Advanced Micro Devices (AMD). And their goods are not essential food, but chips for artificial intelligence (AI) related data centers, which are also in high demand.

Moreover, AMD shares reportedly tumbled 10% additionally on February 5, only because the firm's AI chip revenue failed to be exactly in line with elevated projections of Wall Street analyst pool, which somehow bet on a 80% pace of data centre growth to as much as $4.15 billion YoY. Okay, one might say that Nvidia's "store" sells 8 times more chips that everyone needs. And even remember that Nvidia chips are of better quality, that Nvidia occupies about 80% of global chip market share. Again, Nvidia's last quarter will be finally counted only by February 26, when Nvidia's financial report is scheduled, a month later than in AMD's case. Like most large investment houses, here I have provided growth metrics regarding the major data center segment, which is a proxy for the AI playground, where AMD struggles to compete with Nvidia. Well, AMD CEO Lisa Su admitted that her company's data center sales in the current quarter may go down about 7% from the just-ended quarter, but this announcement was exactly in line with an overall expected decline. Is it really such a big deal that AMD shareholders have to experience pain from seeing their chosen stock falling to a 14-month low, with further need for a 100% rally just to match last year's record prices?

The same Lisa Su declined to give the particular forecast for the company's AI chips, but she said that AMD expects "tens of billions" of dollars in sales "in the next couple of years". And I see no reason to doubt her words. AMD CEO added that the firm is now working to compete against Broadcom (AVGO) in collaborating with its customers like Meta and Microsoft to create custom AI chips for their purposes, as Broadcom helps its partners to design their own chips, contrary to mostly "off-the-shelf" processors by AMD and Nvidia. They know their weaknesses as opportunities for strengthening to work in that direction, so what's wrong with the market's adequacy of perception? Perfect Nvidia is the enemy of good AMD, according to the crowd's opinion. Besides AI chips, AMD is also one of the largest providers of personal computer chips. Until recently, this point was generally the source of their main income. Consumers continue to buy new PCs, which also can handle generative AI tasks, by the way.

Actually, AMD has been the only loss-making company in my large portfolio for a long time, so it even makes me smile now. At least, because it is only a matter of time before AMD's pogo stick ultimately uncoils to come loose. Record annual revenue and earnings have to entail recovering to record market value eventually. I am not sure this will happen in the first half of 2025, even though AMD forecasts its revenue rise between $6.8 billion and $7.4 billion for the current quarter, with the market consensus midpoint being slightly lower at $7.04 billion. If you don't believe me then analysts at Stifel are of the opinion that AMD is well positioned for AI compute and "It is likely" that some of its customers "are waiting for 325/350 systems, which should drive a much stronger second half". Again, the median estimate by the Wall Street's analyst pool was now declined to about $150 per share vs $166.5 before the last downside move, yet even $150 sounds much better compared to $112 on closing price this Wednesday or an intraday low at $106.56 during the last trading session. Anyway, there is a strong technical and psychological support zone near the round figure of $100, from where AMD stock had begun its cool ascension in late 2023.

09.01.2025
VeChain Is Suffering on Rising Borrowing Costs

VeChain (VET) has fallen 12.7% this week, trading at $0.0445, underperforming the broader cryptocurrency market. Bitcoin (BTC), the leading cryptocurrency, has declined by 5.6% to $93,220, with bearish momentum building as it approaches key support at $89,000-$91,000. This decline is largely attributed to tightening monetary conditions in the United States, which continue to weigh on risk assets. Investor confidence is further shaken by significant net outflows from spot BTC-ETFs, which lost $583 million on Wednesday, marking the second-largest single-day outflow on record.

If BTC falls below the critical support level of $89,000-$91,000, VeChain is likely to extend its losses, with prices potentially declining another 10% to $0.0400. A sustained drop in BTC could push VET even lower, towards $0.0300. Conversely, a strong rebound in BTC prices to the $100,000 level could drive VET back up to $0.0500, representing a recovery of approximately 12% from current levels.

10.01.2025
Dollar Strength Is a Given

The very first slice of statistical data on business activity from the United States this year reaffirmed an almost clear irrelevance and even potential hurtfulness of any immediate steps towards further lowering interest rates on U.S. Dollar-nominated loans from a purely economic point of view. The ISM Manufacturing PMI (Purchasing Managers Index), based on polls compiled from executives in over 400 industrial companies in late December, came out at 49.3 points vs 48.4 a month ago and 48.2 in average analyst estimates. This showed that a slowdown was occurring at a slower or even insignificant pace, keeping inflation risks on the table, especially when the price component increased from 50.3 to 52.5 with a similar rate of increase in new orders. Meanwhile, non-manufacturing PMI came out at 54.1 on Tuesday, compared to 53.5 in analyst polls and 52.1 a month ago, with a contribution of business activity components even jumped to a surprising 58.2 against declining from 57.2 in November to only 53.7 in December.

In other words, the economy is not cooling, and is rather in a positive acceleration, which in turn may lead to a recovery in wage rises and therefore to higher demand pressure, which may be reflected soon in higher producer purchase and output prices. Doubts of the major U.S. financial regulator are understandable at this point after its triple rate cut from 5.5% to 4.5% in 2024. The Federal Reserve (Fed) will now pay closer attention not only to consumer inflation measures, but also to producer prices (PPI), which is just going to be released on coming Tuesday, January 14. And so, this will become the next reference point in the further U.S. Dollar’s trajectory. The Greenback index (DX) is picking up steam since reaching a new record high for the last two years at 109.35, with its temporary pullbacks being limited by a 107.50 support area that previously served as a strong multi-month technical resistance.

In this context, the British Pound (GBPUSD) updated its lows since November 2023 to touch 1.2237 on January 9, EURUSD feels quite comfortable within a range between 1.02 and 1.0450, which corresponds to its 2-year bottom, and having a bias towards a possible further decline. The Aussie (AUDUSD) is one-step away from taking the path for a breakthrough to a quite unknown territory of its 5-year lows that were last time recorded when the initial outbreak of the Covid-19 happened.

A varying extent of the American Dollar strength is surely data dependent as the market community is eagerly waiting for the U.S. job data later today. The average expectations on new Nonfarm Payrolls is just a bit above 150,000 vs 227,000 in early December 2024 and nearly 160,000 for the previous four months on average. However, any value close to 150,000, plus or minus 20,000, or any higher number, may be considered as another positive sign for the Greenback, following the ADP national employment report which contained only 122,000 on Wednesday. The oppressive nature of average hourly wage in its dynamics, +0.4% each time from September to December, also matters.

The protective quality of investing more funds into the U.S. Dollar and U.S. bonds against tariff threats is switched on anyway, based on more than a 95% chance for the Fed to keep rates on pause at its January 29 meeting, according to CME's FedWatch tool. Federal Reserve officials never go against a well-established market consensus, when it is almost unanimous, for not to rock the boat of relative market trend stability. The central bankers' reluctance to shift the Fed fund rates lower before mid-March, if not early May, continues to play in favour of short-term speculative transactions on the foreign exchange market, bearing in mind all the listed currency instruments. Some intraday volatility may take place, especially in the case of appearing an abnormal two-digit non-farm value, but not a change in overall direction.

14.01.2025
Merck Becomes Interesting to Be Added to a Portfolio

Merck & Co (MRK) stocks have shown signs of becoming a compelling buy opportunity. Over the past six months, the stock has been in a downtrend, declining 29.8% to $94.50 per share. However, since mid-November, MRK has demonstrated a reversal of momentum, rebounding by 10.0% to reach $104.87 on December 5. Following a brief pullback and consolidation period, the stock has retested the downtrend resistance and appears poised to continue its upward trajectory.

With prices currently positioned to target $110.00, this represents a potential 9-10% upside from the present levels. Setting a stop-loss at $93.50 aligns with a prudent risk management strategy, providing protection against further downside while allowing for upside potential. The recent consolidation phase further supports the case for a breakout, making this an attractive moment to consider initiating or adding to a position in MRK.

Legitimate Cannabis is in Demand Again: Altria

Altria Group is one of the largest tobacco companies in the United States with revenues of $20.7 billion in 2022 and $3.64 in dividend. The company’s strong brand and inelastic demand allowed it to raise prices in order to compensate for its 8% decline in sales. Altria stocks are trading 17% off their peak prices and could be interesting for value investors.

The company is a bright example of how to accept mistakes. Altria has acquired 45% of Cronos Group that has operations in the cannabis sector, but has recognised losses of $438 million in December 2022, and suspended any further investments in the company. The decision was made because the company was showing no signs of progress and no signs of generating revenues as the United States has not made the decision, on the Federal level, to legalise cannabis. There are also a lot of peers in the sector, like Constellation Brands, that have invested over $4 billion in Canopy Growth.

So, the decision of Altria’s management seems to be a wise and timely one as the company may return to this business at any moment, when the situation gets more favourable.

2404
Legitimate Cannabis is in Demand Again: Tilray

Tilray is another cannabis producer from Canada. Its stocks surged amid expectations of marijuana legalisation in the United States, but are now trading far below their peaks of $67 in 2021. The current price at $3 per share, is somewhat attractive as long-term investments.

The majority of TLRY revenues do not come from marijuana sales although the company does control 8.3% of the cannabis market in Canada. Tilray receives 34% of its revenues from cannabis sales. It is the only cannabis producer in Canada that has positive adjusted EBITDA, and sustainable financials overall. The company has cash and cash equivalents of $433.5 million with a debt of $593 million.

Tilray has large greenhouses in Canada and can easily boost production of cannabis if it becomes legal for the whole territory of the United States. The company has invested $165.7 million into its U.S. company MedMen that conducts operations in many American states.

2571
Legitimate Cannabis is in Demand Again: Canopy Growth

Canopy Growth stocks were the most popular before marijuana became legal in Canada. However, after weak financial results performed for a long period of time, CGC prices returned to where they were at the end of 2018. The company’s latest earning report for Q3 2022 provided mixed impressions as revenues were down by 10% year-on-year to $117.9 million, while gross margin was up to 10% from -52%. Cash and cash equivalents were down by 42% year-on-year to $1.1 billion. The amount of cash decreased dramatically as the company is heavily investing in its business in the United States, where it has greater potential than Canada. The company’s management sees this expansion as once in a lifetime opportunity and is willing to bet everything on the U.S. in its effort to consolidate its operations. CGS is trying to get control of its existing businesses in the U.S. where it already has a share of the market: Jetty Extracts (vaping), Wana Brands (a maker of marijuana-infused edibles) and Acreage (a multi-state operator).

Biosteel sport beverages, that are distributed via Walmart and delivered sales up by 299% year-on-year during the reporting quarter, is the only profitable segment for CGS. This is not the best result for a company that specialises in recreational cannabis production. Investors seem to appreciate management’s efforts to risk everything for expansion in the U.S., but the future of the company is entirely dependent on this venture.

2848
Low Risk Purchases in the Bearish Market: Salesforce

Salesforce is a leader of the CRM systems segment. Its stocks are trading at 47% off their peaks. The company continues to post strong business growth despite being in the market for a long time. It has strong financials and abilities to reward its investors. The last quarter revenue reported by Salesforce rose by 14% year-on-year to $7.8 billion, while its operational margin grew by 290 basis points to 22.7%. This is quite impressive as the company suffered because the strong Dollar undermined its revenues outside the U.S. The company’s management has also approved a buy-back program for $1.7 billion.

Management estimates the company will increase its operational margin to 25% in the next couple of years and boost its revenues to $31 billion during this fiscal year, or by 17%. Salesforce announced the cut of 10% of its staff in order to increase profitability. This is quite a common strategy in the tech sector to keep business expansion going.

The company is also active in the M&A market. The last of its acquisitions is the Slack platform that has posted revenues up by 46% during the reporting quarter. Thus, investors may have a wide variety of outstanding products as they buy CRM stocks.

1857
274

Join our community

Share your professional and amateur observations, exchange experiences, anticipate developments

Category
All
Stocks
Crypto
Etf
Commodities
Indices
Currencies
Energies
Metals
Instruments
Author
All
Metadoro
Contributors